FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells

BACKGROUND: Cervical cancer is one of the most common causes of cancer‐associated mortality among affected women in the world. At present, treatment with weekly cisplatin plus ionizing radiation (IR) therapy is the standard regimen for cervical cancer, especially for locally advanced cervical cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jin‐Li, Wang, Jian‐Ping, Chang, Hong, Deng, Sheng‐Ming, Du, Jia‐Hui, Wang, Xiao‐Xiao, Hu, He‐Juan, Li, Dong‐Yin, Xu, Xiang‐Bin, Guo, Wei‐Qiang, Song, Yao‐Hua, Guo, Zhigang, Sun, Min‐Xuan, Wu, Yi‐Wei, Liu, Song‐Bai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912068/
https://www.ncbi.nlm.nih.gov/pubmed/31670906
http://dx.doi.org/10.1002/cam4.2615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912068/
https://www.ncbi.nlm.nih.gov/pubmed/31670906
http://dx.doi.org/10.1002/cam4.2615

Ejemplares similares